MISSISSAUGA, January 5, 2022 / Canadian Analytical Laboratories (“CAL” or “the Company”) a leading provider of analytical testing, method development, validation and research services to the regulated health and food products industries in Canada today announced that the Company has been granted a license from Health Canada to possess and conduct laboratory analysis for Psilocybin and Psilocin. This license is an addendum to the company’s current Health Canada Controlled Substances License.
Psilocybin (PB) and Psilocin (PC) are psychoactive or hallucinogenic indole alkaloids produced by numerous mushroom species that are also commonly referred to as “magic mushrooms”. Both substances are controlled under the Controlled Drugs and Substances Act (CDSA). According to Health Canada, “there is increasing interest in the potential therapeutic uses of psilocybin. At this time, there are no approved therapeutic products containing psilocybin in Canada”.
Presently, Health Canada is granting licenses and exemptions to health care professionals and related companies for the purpose of conducting clinical studies, mushroom production, psilocybin extraction, and laboratory testing. The license will allow the Company to support organizations that are researching and developing groundbreaking therapies using psilocybin and psilocin to potentially treat mental health issues such as depression, PTSD, and addiction, as well studying its ability to treat conditions such as anxiety, obsessive compulsive disorder, and problematic substance use.
Canadian Analytical Laboratories will initiate method development projects with selected partners for the quantification of psilocybin and psilocin in mushroom matrices that have been compounded into different pharmaceutical dosage forms.
Canadian Analytical Laboratories is already licensed and well experienced with rapidly developing analytical methodologies for several other controlled substances and therapeutically interesting molecules. According to Dr. Christian Sood, CEO of Canadian Analytical Laboratories, “this approval provides an important addition to our robust R&D initiatives to develop analytical methodologies that provide foundational support for the development of novel therapeutics in Canada.”
About Canadian Analytical Laboratories.
CAL is a leading provider of analytical testing, Rapid Method Development, Validation Studies, Quality Control Testing and Stability Studies for raw materials and regulated finished products. For over 30 years, the Company has served North American companies in the natural health products, pharmaceuticals, food and beverage, cosmetics, and personal care products industries, and Canadian-based cannabis companies. The Company’s long-standing commitment and leadership and innovation in the industry and to Research and Development has earned CAL a reputation for excellence. Canadian Analytical Laboratories is a member of the Reena Group of Companies.
Please contact us for more information
